@18KHarmoni. Kalau awak duduk kutuk saja Kanger, adakah awak rasa ia akan memberi kebaikan kepada pemegang saham sedia ada yang berada di tingkat atas?
Saya bukannya agen promoter berbayar, tetapi salah seorang pemegang saham Kanger yang tersekat beli Kanger pada harga 10.5 sen baru-baru ini.
@18KHarmoni dan olangbolo. Apahal ada personal masalah ke dengan saya? Promoter bodoh saja. He He
Atau rancangan SPEKULATIF AWAK Untuk burukkan Kanger dah terbongkar. Nak dapatkan harga rendah.
Kata Kanger scam mou, tapi asyik dok tunggu kaunter ni saja. Apa hal benda mau cari.
Yang tambah tukar akaun bukan saya. Yang cipta double atau triple akaun tu macam olongbolo barangkali. Entah-entah twin atau triplet siapa lah tu. He He
The price of Kanger's share is not subject to the attendance of me or other promoter in this forum. Also will not subjected to the naysayer's comments. The price of any shares will depend on the market forces. The supply and demand for the specific share in the market will determine the share price.
even big player also jual MOU... u accept then follow lor... dun accept bet euro cup lor... england kick like hell also win... u buy england what, coz u know the star player.. why not other country??... coz u dunno the player mar...
Actually if ppl here see factual errors in the articles written by MZM 2511, just point out. I once pointed out one error and he soon updated it. So he is responsible. No point just telling us d Kanger is useless...if so why we bought Kanger's shares??
olangbolo ada lagi plomoter bolo ni --------------- Okaylah. Saya promoter bodoh. Minta awak pula lah cadangkan analisis awak. Semua orang sedang tunggu analisis awak yang cerdik. Sekadar nak cakap Kanger tipu,orang gi la belakang rumah saya pun boleh buat analisis.
Beri sebablah, apa yang tipu tu. Biar semua orang boleh kaji betul atau tidak.
An update on the prospect of Kanger to be involved as the distributor of Sinopharm Covid-19 vaccine in Malaysia:
Report 1: 9 March 2021.
Kanger International Bhd will receive 10,000 doses of a Covid-19 vaccine developed by state-owned China National Pharmaceutical Group Corp (Sinopharm) for trial purposes.
In a bourse filing today, the group said the 10,000 doses of the vaccine will be for trial purposes and that it will be getting the necessary approvals from the relevant authorities.
“The first batch of vaccines is expected to arrive in May 2021,” Kanger stated. Sinopharm has Covid-19 vaccine candidates that are undergoing stage 3 clinical trials
The government is open to any party that has the capability and clinical data of the Sinopharm Covid-19 vaccine to register it with the National Pharmaceutical Regulatory Agency (NPRA), says Khairy Jamaluddin (pic).
The National Covid-19 Immunisation Programme coordinating minister said that this DID NOT HAVE TO GO THROUGH PHARMANIAGA, the local registration product holder for the Sinovac vaccine.
He said there were several parties interested in bringing the Sinopharm vaccine from China.
No report about it. The time schedule is lapsed. But for me I stressed on their relation with Sinopharm and their ability to be an elected distributor for the vaccine in Malaysia.
By the way, the Sinophar vaccine has been finished their 3rd Trial, and already approved by WHO.
On the Sputnik Covid-19 vaccine produced by Russia, Khairy said that Duopharma Biotech Bhd’s wholly-owned subsidiary, Duopharma (M) Sdn Bhd (DMSB), which holds the distribution rights to the product, has three months to register the vaccine with the National Pharmaceutical Regulatory Agency (NPRA), after inking an agreement with the government earlier this month.
He said that the NPRA still requires further information on the vaccine.
“However, NPRA also said that it would simplify the registration process if Sputnik gets emergency use (status) from the World Health Organisation (WHO). Sputnik has not received the EUL from WHO yet,” he said, referring to the Emergency Use Listing.
“However, NPRA also said that it would simplify the registration process if Sputnik gets emergency use (status) from the World Health Organisation (WHO). -------------------- I want to stress on this.
If the Sinopharm was truly just registered with NPRA, the process of approval should be more shorter in time compared with the vaccine candidate which not been approved by WHO yet.
Bingo....If Sinopharm was truly just registered with NPRA. The big question is "IF" which means don't know, unsure, not confirmed.
If the Sinopharm was truly just registered with NPRA, the process of approval should be more shorter in time compared with the vaccine candidate which not been approved by WHO yet.
Itu saja kah yang awak boleh cakap. Kalau nak kaunter atau menidakkan pandangan saya pun jadilah sedikit rasinal dengan pandangan bernas dan bukti yang awak boleh kemukakan.
Saya tak suka cakap kosong seperti setengah orang. Ada bukti dan pakai logik.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
MZM2511
4,548 posts
Posted by MZM2511 > 2021-06-18 10:32 | Report Abuse
@18KHarmoni. Kalau awak duduk kutuk saja Kanger, adakah awak rasa ia akan memberi kebaikan kepada pemegang saham sedia ada yang berada di tingkat atas?
Saya bukannya agen promoter berbayar, tetapi salah seorang pemegang saham Kanger yang tersekat beli Kanger pada harga 10.5 sen baru-baru ini.